In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients

Kenneth V.I. Rolston, Maria E. Alvarez, Kou Ching Hsu, Gerald P. Bodey

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The activity of three new antimicrobial agents [cefpirome (HR 810), BMY 28142, WIN 49375], and imipenem was compared to that of four currently available agents, ceftazidime, aztreonam, timentin and piperacillin, against 253 bacterial isolates from cancer patients. The activity of all four agents not yet in clinical use at our institution was significantly greater than that of the four antibiotics already in use.

Original languageEnglish (US)
Pages (from-to)453-457
Number of pages5
JournalJournal of Antimicrobial Chemotherapy
Volume17
Issue number4
DOIs
StatePublished - Apr 1986

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients'. Together they form a unique fingerprint.

Cite this